Catherine Novack
Stock Analyst at Jones Trading
(0)
# 4581
Out of 5,270 analysts
20
Total ratings
27.27%
Success rate
-16.99%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ProQR Therapeutics | Initiates Coverage On: Buy | 11 | 2.12 | 418.87% | 1 | Feb 12, 2025 | |
Korro Bio | Initiates Coverage On: Buy | 130 | 22.86 | 468.68% | 1 | Nov 18, 2024 | |
Capricor Therapeutic... | Initiates Coverage On: Buy | 40 | 13.62 | 193.69% | 1 | Nov 18, 2024 | |
Equillium | Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 1, 2024 | |
Gritstone Bio | Downgrades: Hold | n/a | n/a | n/a | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 16 | 10.09 | 58.57% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 2.64 | 430.3% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 13 | 3.07 | 323.45% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 1.26 | 534.92% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 4.12 | 142.72% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 1.54 | 549.35% | 1 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 2.24 | 882.14% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 2.82 | 5573.76% | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | n/a | n/a | 1 | Oct 4, 2021 |